How will precision medicine define 21st-century therapeutics? What will future healthcare look like? And what actually lies ‘beyond the pill’?
In the latest edition of Research Horizons Professor Chris Lowe, Director of the Cambridge Academy of Therapeutic Sciences, takes the long view on the future of therapeutics.
Covering personalised and regenerative medicine, machine learning in healthcare and beyond-the-pill services such as wearable devices, Professor Lowe explores the fast-changing therapeutics sector. He considers the implications for regulatory, legal and policy environments as well as the future of business, and explains how Cambridge is well placed to drive innovation in this highly multidisciplinary therapeutic scenario.
‘Future healthcare will have a different geometry... sophisticated diagnostic tools, cloud-based applications, artificial intelligence... an extensive toolbox of therapeutic approaches, all personalised to the individual.’
Click here for the full article and contact us for more information on the work of the Cambridge Academy of Therapeutic Sciences.